Merontos, Chloe Belle .
HRN: 25-92-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
10/08/2024
10/15/2024
IV
21mg
Q24h
T/c Neonatal Conjunctivitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes